Prostate cancer co-opts a unique set of cellular pathways in its initiation and progression. The heterogeneity of prostate cancers is evident at earlier stages, and has led to rigorous …
A Dimakakos, A Armakolas… - BioMed research …, 2014 - Wiley Online Library
Prostate‐specific antigen (PSA) is the main diagnostic tool when it comes to prostate cancer but it possesses serious limitations. Therefore, there is an urgent need for more sensitive …
The clinical course of prostate cancer is highly variable. Current prognostic variables, stage, and Gleason score have limitations in assessing treatment regimens for individual patients …
Androgen receptors (ARs) play a critical role in the development of prostate cancer. Targeting ARs results in important salutary effects in this malignancy. Despite mounting …
R Liu, J Zhou, S Xia, T Li - Clinical and Translational Oncology, 2020 - Springer
Background The specific association between PTEN deletion or ERG rearrangement and the recurrence of prostate cancer (PC) treated with radical prostatectomy (RP) or …
Phosphatase and tensin homolog (PTEN) and ETS-related gene (ERG) mutations are commonly found in prostate cancer. Although mouse studies have demonstrated that PTEN …
EJ Pietzak, JA Eastham - Current urology reports, 2016 - Springer
Multimodal strategies combining local and systemic therapy offer the greatest chance of cure for many with men with high-risk prostate cancer who may harbor occult metastatic disease …
T Gao, Y Mei, H Sun, Z Nie, X Liu, S Wang - Biomedicine & …, 2016 - Elsevier
Objective Phosphatase and tensin homolog (PTEN) deleted on chromosome 10, a tumor suppressor that negatively regulates the phosphoinositide-3-kinase (PI3 K) which has been …
O Voulgari, D Goutas, A Pergaris… - Current Issues in …, 2023 - mdpi.com
Purpose: The aim of our study was to observe the associations between the ETS-related gene (ERG) and the phosphatase and tensin homolog gene (PTEN) immunoexpression in …